Multivitamin use may cut risk of chemo-induced neuropathy

September 13, 2017

(HealthDay)—Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy, according to a study published online Sept. 1 in the Journal of the National Cancer Institute.

Gary R. Zirpoli, Ph.D., from the Roswell Park Cancer Institute in Buffalo, N.Y., and colleagues examined use of dietary supplements before and during treatment in relation to CIPN using data from questionnaires completed by 1,225 patients. The authors assessed supplement use in relation to CIPN; they used the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE v. 3.0) and the self-reported Functional Assessment of Cancer Therapy/Gynecologic Oncology Group Neurotoxicity (FACT/GOG-Ntx) subscale.

The researchers found that there was an association for multivitamin use before diagnosis with reduced symptoms of CIPN (CTCAE-adjusted odds ratio, 0.6 [95 percent confidence interval, 0.42 to 0.87]; FACT/GOG-Ntx-adjusted OR, 0.78 [95 percent confidence interval, 0.61 to 1]). There was a marginal inverse correlation for use during treatment with CIPN (CTCAE-adjusted odds ratio, 0.73 [95 percent confidence interval, 0.49 to 1.08]; FACT/GOG-Ntx-adjusted odds ratio, 0.77 [95 percent confidence interval, 0.6 to 0.99]). There was no significant correlation for other supplement use, either before diagnosis or during treatment, with CIPN.

"Multivitamin use could be a surrogate for other related behaviors that are the actual drivers of the association with reduced CIPN," the authors write.

The study was partially funded by Amgen.

Explore further: Occult cancer found in ~5 percent with unprovoked VTE

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Occult cancer found in ~5 percent with unprovoked VTE

August 23, 2017
(HealthDay)—About one in 20 patients with unprovoked venous thromboembolism (VTE) have occult cancer detected within one year, according to a review published online Aug. 22 in the Annals of Internal Medicine.

Radioiodine therapy for thyroid cancer doesn't up stroke risk

August 21, 2017
(HealthDay)—Radioiodine (I-131) therapy for thyroid cancer is not associated with increased risk of stroke, according to a study published online Aug. 16 in Head & Neck.

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Survey puts disabling chemotherapy side effect in focus

June 5, 2017
Thousands of Australian cancer survivors experience chemotherapy-induced peripheral neuropathy (CIPN), but little is known about its impact on a national level.

Stem cell factor tied to reduced risk of cardiac events, death

September 1, 2017
(HealthDay)—High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine.

No link for tea, coffee intake with barrett's esophagus

May 5, 2016
(HealthDay)—After adjustment for confounding variables there is no correlation between the risk of Barrett's esophagus (BE) and tea or coffee consumption, according to a study published in the May issue of Clinical Gastroenterology ...

Recommended for you

Research team discovers drug compound that stops cancer cells from spreading

June 22, 2018
Fighting cancer means killing cancer cells. However, oncologists know that it's also important to halt the movement of cancer cells before they spread throughout the body. New research, published today in the journal Nature ...

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

Higher body fat linked to lower breast cancer risk in younger women

June 21, 2018
While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true ...

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.